cathepsin S inhibitors (Roche)

N/A

Report date: 2025/01/26 19:17:49
NME

Base Information

Drug Namecathepsin S inhibitors (Roche)
Drug Alias NameRO-5461111
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCathepsins inhibitors
TargetsCathepsins
Therapy Area/IndicationsAutoimmune DiseasesCardiovascular DiseasesXerophthalmia +[4
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesF. Hoffmann-La Roche Ltd
China Registration ClassN/A

Develop Information

Active CompaniesF. Hoffmann-La Roche Ltd
Inactive CompaniesN/A
Active IndicationsAutoimmune DiseasesCardiovascular DiseasesXerophthalmia +[4
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A